We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $608K | 0.02% |
3,803
| – | – |
2016 Q4
21 quarters
|
|
377
State Street SPDR S&P Regional Banking ETF
KRE
$3.31B
| $606K | 0.02% |
8,638
+1,250
| +17% | +$91.1K |
2016 Q4
21 quarters
|
|
378
Marriott International
MAR
$101B
| $604K | 0.02% |
3,423
-209
| -6% | -$34.7K |
2016 Q4
21 quarters
|
|
|
AMYT
379
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $604K | 0.02% |
+74,068
| New | +$668K |
2022 Q1
0 quarters
|
|
380
Delta Air Lines
DAL
$51.4B
| $602K | 0.02% |
15,313
+83
| +0.5% | +$3.23K |
2016 Q4
21 quarters
|
|
381
iShares Russell Mid-Cap Growth ETF
IWP
$19.3B
| $601K | 0.02% |
5,892
-480
| -8% | -$47.8K |
2016 Q4
21 quarters
|
|
382
BOK Financial
BOKF
$7.6B
| $600K | 0.02% |
6,229
+6,147
| +7,496% | +$635K |
2016 Q4
21 quarters
|
|
383
Capital One
COF
$122B
| $596K | 0.02% |
4,433
+833
| +23% | +$121K |
2016 Q4
21 quarters
|
|
384
TJX Companies
TJX
$159B
| $592K | 0.02% |
9,544
-2,175
| -19% | -$146K |
2016 Q4
21 quarters
|
|
385
Chubb
CB
$136B
| $591K | 0.02% |
2,718
-155
| -5% | -$31.5K |
2016 Q4
21 quarters
|
|
386
eBay
EBAY
$54.7B
| $591K | 0.02% |
9,956
+1,217
| +14% | +$70.9K |
2016 Q4
21 quarters
|
|
387
SEI Investments
SEIC
$12.6B
| $588K | 0.02% |
9,597
+7,697
| +405% | +$458K |
2016 Q4
21 quarters
|
|
388
Humana
HUM
$51.9B
| $587K | 0.02% |
1,335
-106
| -7% | -$44.3K |
2016 Q4
21 quarters
|
|
389
International Flavors & Fragrances
IFF
$23B
| $587K | 0.02% |
4,474
+344
| +8% | +$45.7K |
2016 Q4
21 quarters
|
|
390
Quest Diagnostics
DGX
$26.4B
| $586K | 0.02% |
4,216
-546
| -11% | -$76.1K |
2016 Q4
21 quarters
|
|
391
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $581K | 0.02% |
11,272
+3,856
| +52% | +$205K |
2016 Q4
21 quarters
|
|
392
Lincoln National
LNC
$7.66B
| $580K | 0.02% |
8,659
-802
| -8% | -$54.8K |
2016 Q4
21 quarters
|
|
393
Datadog
DDOG
$95.6B
| $578K | 0.02% |
3,860
+823
| +27% | +$120K |
2020 Q1
8 quarters
|
|
394
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.74B
| $578K | 0.02% |
15,016
-1,149
| -7% | -$43.3K |
2019 Q2
11 quarters
|
|
|
ATVI
395
DELISTED
Activision Blizzard
ATVI
| $572K | 0.02% |
7,113
+1,282
| +22% | +$99.9K |
2016 Q4
21 quarters
|
|
396
Expeditors International
EXPD
$25.8B
| $571K | 0.02% |
5,431
-1,429
| -21% | -$158K |
2016 Q4
21 quarters
|
|
397
Lam Research
LRCX
$347B
| $567K | 0.02% |
10,330
-2,400
| -19% | -$140K |
2016 Q4
21 quarters
|
|
|
FRC
398
DELISTED
First Republic Bank
FRC
| $566K | 0.02% |
3,412
+139
| +4% | +$24.3K |
2016 Q4
21 quarters
|
|
399
MetLife
MET
$63.7B
| $565K | 0.02% |
7,887
+1,080
| +16% | +$73K |
2016 Q4
21 quarters
|
|
400
Rio Tinto
RIO
$147B
| $564K | 0.02% |
7,006
-12
| -0.2% | -$911 |
2016 Q4
21 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.